Christiana Smith1, Yanling Huo2, Kunjal Patel3, Kirk Fetters4, Shannon Hegemann5, Sandra Burchett6, Russell Van Dyke7, Adriana Weinberg1,8,9. 1. Department of Pediatrics, University of Colorado, Aurora, Colorado, USA. 2. Center for Biostatistics in AIDS Research, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, USA. 3. Department of Epidemiology, Center for Biostatistics in AIDS Research, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, USA. 4. Department of Medicine, Harbor-UCLA Medical Center, Torrance, California, USA. 5. College of Medicine, University of Nebraska, Omaha, Nebraska, USA. 6. Department of Pediatrics, Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts, USA. 7. Department of Pediatrics, Tulane University School of Medicine, New Orleans, Louisiana, USA. 8. Department of Medicine, University of Colorado, Aurora, Colorado, USA. 9. Department of Pathology, University of Colorado, Aurora, Colorado, USA.
Abstract
BACKGROUND: Human immunodeficiency virus (HIV)-exposed, uninfected (HEU) infants experience higher rates of morbidity and mortality than HIV-unexposed, uninfected (HUU) infants. Few studies have examined whether particular infections and/or immune responses are associated with hospitalization among HEU infants born in the United States. METHODS: We evaluated a subset of HEU infants enrolled in the International Maternal Pediatric Adolescent AIDS Clinical Trials Group P1025 and/or Pediatric HIV/AIDS Cohort Study Surveillance Monitoring for ART Toxicities studies. We determined seroconversion to 6 respiratory viruses and measured antibody concentrations to 9 vaccine antigens using quantitative ELISA or electrochemiluminescence. Multivariable modified Poisson regression models were fit to evaluate associations of seroconversion to each respiratory virus/family and antibody concentrations to vaccine antigens with risk of hospitalization in the first year of life. Antibody concentrations to vaccine antigens were compared between HEU infants and HUU infants from a single site using multivariable linear regression models. RESULTS: Among 556 HEU infants, seroconversion to respiratory syncytial virus (RSV) and parainfluenza was associated with hospitalization (adjusted risk ratio, 1.95 [95% CI, 1.21-3.15] and 2.30 [1.42-3.73], respectively). Antibody concentrations to tetanus toxoid, pertussis, and pneumococcal vaccine antigens were higher among 525 HEU compared with 100 HUU infants. No associations were observed between antibody concentrations with any vaccine and hospitalization among HEU infants. CONCLUSIONS: RSV and parainfluenza contribute to hospitalization among HEU infants in the first year of life. HEU infants demonstrate robust antibody responses to vaccine antigens; therefore, humoral immune defects likely do not explain the increased susceptibility to infection observed in this population.
BACKGROUND: Human immunodeficiency virus (HIV)-exposed, uninfected (HEU) infants experience higher rates of morbidity and mortality than HIV-unexposed, uninfected (HUU) infants. Few studies have examined whether particular infections and/or immune responses are associated with hospitalization among HEU infants born in the United States. METHODS: We evaluated a subset of HEU infants enrolled in the International Maternal Pediatric Adolescent AIDS Clinical Trials Group P1025 and/or Pediatric HIV/AIDS Cohort Study Surveillance Monitoring for ART Toxicities studies. We determined seroconversion to 6 respiratory viruses and measured antibody concentrations to 9 vaccine antigens using quantitative ELISA or electrochemiluminescence. Multivariable modified Poisson regression models were fit to evaluate associations of seroconversion to each respiratory virus/family and antibody concentrations to vaccine antigens with risk of hospitalization in the first year of life. Antibody concentrations to vaccine antigens were compared between HEU infants and HUU infants from a single site using multivariable linear regression models. RESULTS: Among 556 HEU infants, seroconversion to respiratory syncytial virus (RSV) and parainfluenza was associated with hospitalization (adjusted risk ratio, 1.95 [95% CI, 1.21-3.15] and 2.30 [1.42-3.73], respectively). Antibody concentrations to tetanus toxoid, pertussis, and pneumococcal vaccine antigens were higher among 525 HEU compared with 100 HUU infants. No associations were observed between antibody concentrations with any vaccine and hospitalization among HEU infants. CONCLUSIONS: RSV and parainfluenza contribute to hospitalization among HEU infants in the first year of life. HEU infants demonstrate robust antibody responses to vaccine antigens; therefore, humoral immune defects likely do not explain the increased susceptibility to infection observed in this population.
Authors: Sabelle Jallow; Yasmeen Agosti; Prudence Kgagudi; Megan Vandecar; Clare L Cutland; Eric A F Simões; Marta C Nunes; Melinda S Suchard; Shabir A Madhi Journal: Clin Infect Dis Date: 2019-06-18 Impact factor: 9.079
Authors: Adriana Weinberg; Marisa M Mussi-Pinhata; Qilu Yu; Rachel A Cohen; Volia C Almeida; Fabiana Amaral; Jorge Pinto; Maria L B Teixeira; Regina C M Succi; Laura Freimanis; Jennifer S Read; George Siberry Journal: AIDS Date: 2017-03-13 Impact factor: 4.177
Authors: Brian A Reikie; Shalena Naidoo; Candice E Ruck; Amy L Slogrove; Corena de Beer; Heleen la Grange; Rozanne C M Adams; Kevin Ho; Kinga Smolen; David P Speert; Mark F Cotton; Wolfgang Preiser; Monika Esser; Tobias R Kollmann Journal: Clin Vaccine Immunol Date: 2012-10-31
Authors: Rocio D Marchese; Derek Puchalski; Pamela Miller; Joseph Antonello; Olivia Hammond; Tina Green; Leonard J Rubinstein; Michael J Caulfield; Daniel Sikkema Journal: Clin Vaccine Immunol Date: 2009-01-21
Authors: M Pamela Griffin; Yuan Yuan; Therese Takas; Joseph B Domachowske; Shabir A Madhi; Paolo Manzoni; Eric A F Simões; Mark T Esser; Anis A Khan; Filip Dubovsky; Tonya Villafana; John P DeVincenzo Journal: N Engl J Med Date: 2020-07-30 Impact factor: 176.079